主要收入构成
报告期:2022-12-31
主营产品构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
EMR/ESD类 |
12.85% |
254.35 |
-2.24% |
111.21 |
56.28% |
-3.96% |
ERCP类 |
5.54% |
109.69 |
-14.30% |
43.65 |
60.20% |
2.77% |
EUS/EBUS类 |
1.20% |
23.82 |
31.92% |
13.17 |
44.69% |
5.12% |
代理 |
2.70% |
53.51 |
55.39% |
36.56 |
31.68% |
5.56% |
活检类 |
12.64% |
250.28 |
5.60% |
163.62 |
34.63% |
-0.65% |
可视化产品类 |
9.61% |
190.24 |
1850.61% |
110.60 |
41.86% |
7.08% |
扩张类 |
9.43% |
186.81 |
0.81% |
55.95 |
70.05% |
-0.81% |
其他 |
2.55% |
50.41 |
9.50% |
28.54 |
43.38% |
1.29% |
其他(补充) |
0.34% |
6.70 |
41.35% |
5.78 |
13.80% |
8.03% |
微波消融针 |
6.23% |
123.37 |
-2.15% |
23.41 |
81.02% |
-1.39% |
止血及闭合类 |
36.62% |
725.10 |
-18.71% |
176.95 |
75.60% |
1.73% |
肿瘤消融设备 |
0.30% |
5.84 |
14.97% |
3.79 |
35.22% |
-9.53% |
总计 |
1980.14 |
行业收入构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
其他(补充) |
0.34% |
6.70 |
41.35% |
5.78 |
13.80% |
8.03% |
医疗器械 |
99.66% |
1973.44 |
1.62% |
767.47 |
61.11% |
-3.21% |
总计 |
1980.14 |
地区收入构成(百万) |
名称 |
占总收入比例 |
收入 |
同比变化 |
成本 |
毛利率 |
同比变化 |
内销 |
57.82% |
1145.01 |
-4.58% |
441.43 |
61.45% |
-4.42% |
其他(补充) |
0.34% |
6.70 |
41.35% |
5.78 |
13.80% |
8.03% |
外销 |
41.84% |
828.43 |
11.64% |
326.04 |
60.64% |
-1.18% |
总计 |
1980.14 |